secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001628280-24-046265
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cibus Q3 net loss $201.5M on $181.4M goodwill impairment; cash runway into late Q1 2025
--------------------------------------------------------------------------------

- Net loss $201.5M ($7.63/sh) vs $34.5M ($1.59/sh) YoY; includes $181.4M non-cash goodwill impairment.
- Cash $28.8M; expects funding into late Q1 2025 without additional financing; board evaluating strategic alternatives.
- Initiating $10M annualized cost savings, reducing monthly cash usage ~20%; one-time severance charge in Q4.
- Rice platform: agreements with 4 seed companies, successful HT3 field trials, stacked gene-edited trait results.
- Soybean platform expected operational by year-end 2024; Sclerotinia resistance field trial positive for second mode of action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000162828024046265/0001628280-24-046265-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000162828024046265/cbus-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-046265

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer